))
7.4 million Americans could gain Medicare or Medicaid coverage for anti-obesity drugs under Biden proposal
Manage episode 453571222 series 3609475
内容由Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S.提供。所有播客内容（包括剧集、图形和播客描述）均由 Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S. 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Summary of article found on WREX.com:
The Biden administration proposed expanding Medicare and Medicaid coverage for costly anti-obesity drugs, potentially benefiting millions of seniors and low-income individuals. This could significantly reduce out-of-pocket expenses, but the proposal lacks details and faces uncertainty under the incoming Trump administration, with differing opinions from key appointees.
Currently, limited access due to high drug costs restricts widespread use, and the financial implications for Medicare are substantial, with estimates reaching billions of dollars annually. While some private insurers are covering these medications, state Medicaid programs show varied levels of coverage, highlighting the cost concerns and potential challenges in broader implementation.
11集单集
分享
